本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ImmunoGen

31.23
+0.0000
成交量:- -
成交额:15.18亿
市值:87.24亿
市盈率:-111.52
高:31.23
开:31.23
低:31.23
收:31.23
数据加载中...
2024/02/12

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/02/12

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/02/12

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/02/12

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/02/12

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/02/12

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2024/02/12

重要事件披露

Form 8-K - Current report
2024/02/08

重要事件披露

Form 8-K - Current report
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/31

重要事件披露

Form 8-K - Current report
2024/01/30

重要事件披露

Form 8-K - Current report
2024/01/25

重要事件披露

Form 8-K - Current report